Torrent Pharmaceuticals Limited (TORNTPHARM) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.123x

Based on the latest financial reports, Torrent Pharmaceuticals Limited (TORNTPHARM) has a cash flow conversion efficiency ratio of 0.123x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs10.38 Billion ≈ $112.26 Million USD) by net assets (Rs84.49 Billion ≈ $913.73 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Torrent Pharmaceuticals Limited for the company's overall valuation and market capitalisation.

Torrent Pharmaceuticals Limited - Cash Flow Conversion Efficiency Trend (2005–2026)

This chart illustrates how Torrent Pharmaceuticals Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Torrent Pharmaceuticals Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Torrent Pharmaceuticals Limited ranked by their cash flow conversion efficiency. Explore TORNTPHARM operating cash flow to net income to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Yihai Kerry Arawana Holdings Co Ltd
SHE:300999
0.138x
CLP HLDGS LTD ADR/1 HD 5
F:CLP1
N/A
InterGlobe Aviation Limited
NSE:INDIGO
1.544x
Henkel AG & Co. KGaA
XETRA:HEN
0.041x
OMV Aktiengesellschaft
VI:OMV
0.036x
Charter Communications Inc
NASDAQ:CHTR
0.204x
Bayan Resources Tbk
JK:BYAN
0.092x
Telia Company AB
ST:TELIA
0.136x

Annual Cash Flow Conversion Efficiency for Torrent Pharmaceuticals Limited (2005–2026)

The table below shows the annual cash flow conversion efficiency of Torrent Pharmaceuticals Limited from 2005 to 2026. View TORNTPHARM stock price for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2026-03-31 Rs175.85 Billion
≈ $1.90 Billion
Rs26.32 Billion
≈ $284.64 Million
0.150x -56.05%
2025-03-31 Rs75.91 Billion
≈ $820.94 Million
Rs25.85 Billion
≈ $279.56 Million
0.341x -28.51%
2024-03-31 Rs68.56 Billion
≈ $741.47 Million
Rs32.66 Billion
≈ $353.21 Million
0.476x +24.69%
2023-03-31 Rs61.98 Billion
≈ $670.29 Million
Rs23.68 Billion
≈ $256.09 Million
0.382x +26.14%
2022-03-31 Rs59.53 Billion
≈ $643.79 Million
Rs18.03 Billion
≈ $194.99 Million
0.303x -12.07%
2021-03-31 Rs58.37 Billion
≈ $631.27 Million
Rs20.11 Billion
≈ $217.45 Million
0.344x +19.37%
2020-03-31 Rs48.23 Billion
≈ $521.61 Million
Rs13.92 Billion
≈ $150.52 Million
0.289x -24.18%
2019-03-31 Rs47.24 Billion
≈ $510.92 Million
Rs17.98 Billion
≈ $194.46 Million
0.381x +96.76%
2018-03-31 Rs46.23 Billion
≈ $499.93 Million
Rs8.94 Billion
≈ $96.70 Million
0.193x -16.90%
2017-03-31 Rs43.51 Billion
≈ $470.50 Million
Rs10.13 Billion
≈ $109.52 Million
0.233x -70.92%
2016-03-31 Rs33.89 Billion
≈ $366.56 Million
Rs27.13 Billion
≈ $293.43 Million
0.800x +146.11%
2015-03-31 Rs24.91 Billion
≈ $269.39 Million
Rs8.10 Billion
≈ $87.62 Million
0.325x +3.25%
2014-03-31 Rs19.03 Billion
≈ $205.78 Million
Rs5.99 Billion
≈ $64.82 Million
0.315x +191.92%
2013-03-31 Rs14.22 Billion
≈ $153.82 Million
Rs1.53 Billion
≈ $16.60 Million
0.108x -74.53%
2012-03-31 Rs11.97 Billion
≈ $129.49 Million
Rs5.07 Billion
≈ $54.87 Million
0.424x +9.98%
2011-03-31 Rs10.24 Billion
≈ $110.74 Million
Rs3.95 Billion
≈ $42.67 Million
0.385x +11.56%
2010-03-31 Rs8.31 Billion
≈ $89.87 Million
Rs2.87 Billion
≈ $31.04 Million
0.345x -12.83%
2009-03-31 Rs6.51 Billion
≈ $70.39 Million
Rs2.58 Billion
≈ $27.89 Million
0.396x -16.47%
2008-03-31 Rs5.10 Billion
≈ $55.11 Million
Rs2.42 Billion
≈ $26.14 Million
0.474x +164.43%
2007-03-31 Rs4.10 Billion
≈ $44.37 Million
Rs735.97 Million
≈ $7.96 Million
0.179x +81.59%
2006-03-31 Rs3.48 Billion
≈ $37.62 Million
Rs343.63 Million
≈ $3.72 Million
0.099x +23.72%
2005-03-31 Rs3.16 Billion
≈ $34.12 Million
Rs251.96 Million
≈ $2.72 Million
0.080x --

About Torrent Pharmaceuticals Limited

NSE:TORNTPHARM India Drug Manufacturers - Specialty & Generic
Market Cap
$19.95 Billion
Rs1.84 Trillion INR
Market Cap Rank
#1284 Global
#37 in India
Share Price
Rs4850.00
Change (1 day)
-2.33%
52-Week Range
Rs3514.70 - Rs5122.80
All Time High
Rs5122.80
About

Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil, Germany, Malta, and internationally. The company offers products in various therapeutic areas, including anti-diabetic, anti-microbial, cardiovascular, CNS, urology, gynecology, oncology, gastro-int… Read more